4A9O | Signaling Protein Inhibitor | date | Nov 26, 2011 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | N-Terminal Bromodomain Of Human Brd2 With 5 Ethyl-3-Methyl- 4-Phenyl-1,2-Oxazole | ||||||||||||||
authors | C.W.Chung, P.Bamborough | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Bromodomain Containing 2 Chain: A, B, C Fragment: N-Terminal Bromodomain (Bd1), Residues 67-200 Synonym: Human Brd2 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.78 Å | ||||||||||||
ligand | A9O, EDO, SO4 | enzyme |
| ||||||||||||
Primary reference | Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides., Bamborough P, Diallo H, Goodacre JD, Gordon L, Lewis A, Seal JT, Wilson DM, Woodrow MD, Chung CW, J Med Chem. 2012 Jan 26;55(2):587-96. Epub 2012 Jan 11. PMID:22136469 |
Data retrieval |
View 4A9O in 3D |
Visual 3D analysis of 4A9O |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4A9O |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |